You have participated in the very first All Hands Workshop of the new and improved CID Global Commercial Functions galaxy within the DT&IT PH Commercial IT & Digital universe. In Berlin or attending virtually, you spent your time warmly welcoming some colleagues to the fold, while you also rejoyced in revigorating established bonds. You discussed the new team structure, the positioning & value contribution of the individual teams and had a deep-dive into our three in-focus topics CX, Launch Excellence, and Generative AI. Well done, you! Image created with runwayml.com (based on Rolf / 1993)

I’ve met Jesus during May 2023, probably in Berlin. Jesus works at Bayer Pharmaceuticals currently as the Head of Business Disruption. If you are into Stranger Things, Breakthrough Innovations, AcceleRed, TeamRed, Science4Berlin, STEM4Health, Hackathons, Biotech, Digital Health, Startups, Entrepreneurship, Intrapreneurship, Web3, Web5, Networking For Health, Science, Technology, Pharma, Exobiology, Space, Science Fiction, Germany, Cuba, you can connect with Jesus in LinkedIn: https://www.linkedin.com/in/yeysus/ Twitter: https://twitter.com/yeysus Meetup: https://www.meetup.com/members/45080772/ Web3: yeysus.eth/.tez/.near Some of his POAPs collections in Welook.io: Bayer: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/1 Corporates: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/2 Animated: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/5 Ladies: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/8 Beautiful: https://welook.io/0x74839F2fF3bb6F98E5f120329A76A89f52b95DCC/poap/c/9 Art by Stable Diffusion.

Congratulations! You have participated in the HemoVR Experience during the initial 2023 MVP phase! With this virtual reality educational program you learned to better understand personalized treatment options for hemophilia A patients. Especially how monitoring the Pharmacokinetic level (PK level) can help in aiming higher in life, i.e. being more active with better protection. Another subject was joint protection, an often neglected topic when discussing treatment plans.